Briefing News Psychedelics Psyence Group Pure Extracts

Pure Extracts Signs LOI For Joint Venture With Psyence Group

Pure Extracts (CSE: PULL) has entered into a letter of intent for a proposed joint venture with Psyence Group (CSE: PSYG). The proposed venture is to be focused on the extraction of psilocybin from mushrooms. The venture partner, Psyence, is one of the first commercial psilocybin cultivation and extraction facilities operating under a federally legal …

Briefing News Psyched Wellness Psychedelics

Psyched Wellness Launches Study On Mushroom Extract Focused On Gut Health

Psyched Wellness (CSE: PSYC) this morning issued a very brief press release related to ongoing studies. The firm has initiated yet another study on its proprietary AME-1 extract, this time with the study focused on gut health. To be conducted through the firms contract research organization, KGK Sciences, the study will look to further examine …

Briefing News Pharmather Psychedelics

PharmaTher Sponsors Research For Novel Delivery Of Ketamine

PharmaTher Inc (CSE: PHRM) this morning announced that it has entered into a sponsored research agreement. The agreement, which was signed with The Queen’s University of Belfast, will see the development of a patented hydrogel-forming microneedle patch for use with ketamine. More specifically, the microneedle patch is being developed to work with KETABET, PharmaTher’s proprietary …

Briefing News Psychedelics Revive Therapeutics

Revive Therapeutics Reports Successful Results Using Psilocybin To Treat Traumatic Brain Injury

Revive Therapeutics (CSE: RVV) this morning revealed that it has received positive results for a pre-clinical study that evaluated the efficacy of psilocybin in the treatment of mild traumatic brain injury. The pre-clinical trial was conducted in a rodent model of such an injury. Conducted by the National Health Research Institute, the study focused on …

Briefing News Psyched Wellness Psychedelics

Psyched Wellness Files Patent Application For Proprietary AME-1 Extraction Process

Psyched Wellness (CSE: PSYC) has begun the process of protecting its intellectual property. The firm this morning announced that it has submitted a provisional patent application with that of the United States Patent and Trademark Office. The provisional patent application is for that of the firms extraction process for the Amanita Muscaria extract AME-1. The …

Briefing Psychedelics Red Light Holland

Red Light Holland Sees Sales And Import Of Psychedelic Truffles Into Canada

Red Light Holland (CSE: TRIP) this morning reported that it has seen the successful sale and import of its psychedelic truffles, referred to as iMicrodose Packs, into Canada under a Health Canada permit. The transaction saw the firms products imported by CCrest Laboratories, in partnership with Shaman Pharma. The arrangement is significant for Red Light, …

Briefing Cannabis Creso Pharma Halucenex News Psychedelics

Creso Pharma Enters Psychedelics Space With Acquisition Of Canadian Firm

Creso Pharma (ASX: CPH) this morning announced that it will be entering the psychedelic space, the first such listed firm on the ASX to do so. The company is set to acquire Halucenex, a psychedelic-assisted psychotherapy firm based in Canada. The acquisition will bring the company into the emerging psychedelics sector, which is estimated to …